Effects of single-agent bortezomib (btz) as post-transplant consolidation on multiple myeloma (MM)-related bone disease: first results from a multicenter, randomized phase 2 study

Orhan Sezer, Meral Beksac, Roman Hajek, Gülsan Sucak, Seckin Cagirgan, Werner Linkesch, Olga Meltem Akay, Gabriele Armbrecht, Torben Plesner, John Snowden, Hareth Nahi, Zafer Gülbas, Anna Potamianou, Cathrine Couturier, Robert Olie, Caroline Feys, Nathalie Allietta, Evangelos Terpos

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdato2014
StatusUdgivet - 2014
BegivenhedAnnual Congress of the European Hematology Association - Milano, Italien
Varighed: 12. jun. 201415. jun. 2014
Konferencens nummer: 19

Konference

KonferenceAnnual Congress of the European Hematology Association
Nummer19
LandItalien
ByMilano
Periode12/06/201415/06/2014

Citationsformater